Metabolic syndrome;Síndrome metabólico

Revista Espanola de Pediatria

Volumn 65, Issue 5, 2009, Pages 423-432

  Muñoz Calvo, María Teresa ^a   Argente, J ^b  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Diabetes; Glycemia; Insulin; Obesity; Triglycerides

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET; DISEASE ASSOCIATION; DYSLIPIDEMIA; EXERCISE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERINSULINISM; HYPERTENSION; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PSYCHOLOGICAL ASPECT; REVIEW;

EID: 71049165604     PISSN: 0034947X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML; American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009; 119: 628-647
2. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607
3. Golley RK, Magarey AM, Steinbeck KS, Baur LA, Daniels LA. Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management study. Int J Obes (Lond). 2006; 30(5): 853-860
4. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications:Report of a WHO Consultation. Geneva: Department of Non-communicable Disease Surveillance, World Health Organization, 1999.
5. ATPIII. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
6. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a Metabolic Syndrome Phenotype in Adolescents Findings from the Third National Health And Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157: 821-827
7. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Ped Diabetes 2007; 8: 299-306.
8. López-Capapé M, Alonso, Colino E, Mustieles C, Corbatón J, Barrio R. Frequency of the metabolic syndrome in obese Spanish pediatric population. Eur J Endocrinol 2006; 155: 313-319.
9. Sen Y, Kandemir N, Alikasifoglu A, Gonc N, Ozon A. Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. Eur J Pediatr. 2008;167:1183-1189
10. Atabek M, Pirgon O, Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diab Res Clin Pract 2006; 72: 315-321. (Pubitemid 44250897)
11. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med. 2009;163:371-377
12. Cali AM, Caprio S. Obesity in children and adolescents. J Clin Endocrinol Metab. 2008; 93(11 Suppl 1):S31-6
13. Cole T, Bellizi M, Flegal K, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243 (Pubitemid 30240471)
14. Serra Ll, Ribas L, Aranceta J, Perez C, Saavedra P. Epidemiologia de la obesidad infantil y juvenil en España. Resultados del estudio enKid (1998-2000). En: Obesidad infantil y juvenil. Estudio enKid. Eds: Serra L, Aranceta J. Ed Masson. Barcelona 2001, págs: 55-62.
15. Moreno LA, Mesana MI, Fleta J, Ruiz JR, González-Cross M, Sarriá A et al. Overweight, obesity and body fat composition in spanisch adolescents. The AVENA Study. Ann Nutr Metab 2005; 49: 71-76
16. Carrascosa A, Fernández JM, Fernández C, Ferrández-Longás A, López-Siguero JP, Sánchez E, et al; Grupo Colaborador Español. Spanish cross-sectional growth study 2008. Part II. Height, weight and body mass index values from birth to adulthood. An Pediatr (Barc). 2008; 68: 552-569
17. Goran MI, Gower BA. Longitudinal study on puberty insulin resistance. Diabetes 2001; 50: 2444-2450 (Pubitemid 33642760)
18. Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol. 2008;159 Suppl 1:S67-74.
19. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 2000; 85: 1401-1406 (Pubitemid 32289480)
20. Reinehr T, Kleber M, Toschke AM. Small for gestational age status is associated with metabolic syndrome in overweight children. Eur J Endocrinol. 2009; 160: 579-584
21. Arslanian S, Kalhan SC. Correlations between fatty acid and glucose metabolism: potential explanation of insulin resistance of puberty. Diabetes 1995; 43: 908-914 (Pubitemid 24196424)
22. Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents. Diabetes Care 2004; 27: 314-319.
23. García-Cuartero B, García C, Jiménez C, González A, Calvo C, Alcázar MJ, et al. El Índice HOMA y QUICKI, insulina y péptido C en nifios sanos. Puntos de corte de riesgo cardiovascular. An Pediatr (Barc). 2007: 66: 481-490
24. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab. 1991; 72: 277-282 (Pubitemid 21921688)
25. Viner R, Segal T, Lichtarowicz-Krynska E. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 2005; 90: 10-14 (Pubitemid 40052245)
26. Tapia L, López-Siguero JP, Jurado A. Prevalencia de síndrome metabólico y sus componentes en niños y adolescentes con obesidad. An Pediatr (Barc) 2007; 67: 352-361
27. Urakami T, Morimoto S, Nitadori Y, Harada K, Owada M, Kitagawa T. Urine glucose screening program at schools in Japan to detect children with diabetes and its outcome-incidence and clinical characteristics of childhood type 2 diabetes in Japan. Pediatr Res. 2007 Feb; 61(2):141-145
28. Sinha R, Fisco G, Teague B, Tamborlane WV, Banyas B, Allen K et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802-810
29. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29 Suppl 1: S43-S48.
30. De Ferranti SD, Osganian SK. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc Dis Res. 2007;4:285-296
31. Reinehr T, Schober E, Wiegand S, Thon A, Holl R; DPV-Wiss Study Group. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch Dis Chid 2006; 91: 473-531
32. Daniels SR, Greer FR; Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008; 122: 198-208.
33. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2362-2374.
34. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000; 149: 139-150 (Pubitemid 30125982)
35. Wärnberg J, Marcos A. Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol. 2008;19:11-15
36. Winer JC, Zern TL, Taksali SE, Dziura J, Cali AM, Wollschlager M et al. Adiponectin in childhood and adolescents obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 2006; 91: 4415-4423
37. Galili O, Versari D, Sattler KJ, Olson ML, Mannheim D, McConnell JP, et al. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol. 2007; 292: H904-911. (Pubitemid 46246940)
38. Kelly AS, Steinberger J, Kaiser DR, Olson TP, Bank AJ, Dengel DR. Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children. J Cardiometab Syndr. 2006; 1: 248-252
39. Kelly AS, Wetzsteon RJ, Kaiser DR, Steinberger J, Bank AJ, Dengel DR. Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise. J Pediatr. 2004; 145: 731-736 (Pubitemid 39586608)
40. Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, Girardet JP, Bonnet D. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet. 2001;27:1400-1404
41. Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond). 2008; 32: 1035-1041
42. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006; 118: 1388-1393 (Pubitemid 46393782)
43. Biltoft CA, Muir A. The metabolic syndrome in children and adolescents: a clinician's guide. Adolesc Med State Art Rev. 2009;20:109-120
44. Chen AK, Roberts CK, Barnard RJ. Effect of a short-term diet and exercise intervention on metabolic syndrome in overweight children. Metabolism 2006; 55: 871-878.
45. Monzavi R, Dreimane D, Geffner ME, Braun S, Conrad B, Klier M, Kaufman FR. Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention. Pediatrics 2006, 117(6): e1111-8. Epub 2006. (Pubitemid 46071206)
46. Dunican KC, Desilets AR, Montalbano JK. Pharmacotherapeutic options for overweight adolescents. Ann Pharmacother. 2007; 41(9): 1445-1455
47. Van Mil EG, Westerterp KR, Kester AD, Delemarre-Van de Waal HA, Gerver WJ, Saris WH. The effect of sibutramine on energy expenditure and body composition in obese adolescents. J Clin Endocrinol Metab. 2007; 92(4): 1409-14.
48. The TODAY Study Group, Zeitler P, Epstein L, Grey M, Hirst K, Kaufman F, Tamborlane W, Wilfley D. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes. 2007; 8(2): 74-87.
49. Miller JL, Silverstein JH. The treatment of type 2 diabetes mellitus in youth: which therapies? Treat Endocrinol. 2006; 5(4): 201-210
50. Kwiterovich PO Jr. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab. 2008; 93: 4200-4209 (Pubitemid 352789511)
51. Goldbacher EM, Matthews KA. Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature. Ann Behav Med. 2007; 34: 240-252